Identification of mutations in proviral long terminal repeats of HIV type 1-infected subjects naive to drug therapy

AIDS Research and Human Retroviruses

Volumn 20, Issue 9, 2004, Pages 1019-1021

  Copeland, Karen F T ^a   Chen, Zhaoxia ^b   Fiebig, Marnie ^b   Ni, Lisa ^a   Savoy, Sherie ^c   Smaill, Fiona M ^c   Rosenthal, Kenneth L ^c   Kim, John E ^b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b HEALTH CANADA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR SP1;

ARTICLE; BLOOD SAMPLING; DNA SEQUENCE; GENE DELETION; GENE DUPLICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS MUTATION; VIRUS TRANSCRIPTION;

BASE SEQUENCE; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROVIRUSES; SEQUENCE ANALYSIS, DNA;

EID: 5644282755     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2004.20.1019     Document Type: Article

References (8)

1. Kwon H, Pelletier N, DeLuca C, Genin P, Cisternas S, Lin R, Wainberg MA, and Hiscott J: Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells. J Biol Chem 1998;273:7431-7440.
2. Estable MC, Bell B, Hirst M, and Sadowski I: Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription. J Virol 1998;72:6465-6474.
3. Berkhout B and Jeang KT: Trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: A quantitative analysis. J Virol 1989;63:5501-5504.
4. Li Y, Mak G, and Franza BR Jr: In vitro study of functional involvement of Sp1, NF-kappa B/Rel, and AP1 in phorbol 12-myristate 13-acetate-mediated HIV-1 long terminal repeat activation. J Biol Chem 1994;269:30616-30619.
5. Copeland KF, McKay PJ and Rosenthal KL: Suppression of the human immunodeficiency virus long terminal repeat by CD8+ T cells is dependent on the NFAT-1 element. AIDS Res Hum Retroviruses 1996;12:143-148.
6. Goméz-Roman VR, Vazquez JA, del Carmen Basualdo M, strada FJ, Ramos-Kuri M, and Soler C: nef/long terminal repeat quasi-species from HIV type 1-infected Mexican patients with different progression patterns and their pathogenesis in hu-PBL-SCID mice. AIDS Res Hum Retroviruses 2000;16:441-452.
7. Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, and Sadowski IJ: Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 1996;70:4053-4062.
8. Zhang L, Huang Y, Yuan H, Chen BK, Ip J, and Ho DD: Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-1alpha region but lacking NF-kappaB binding sites. J Virol 1997;71:1651-1656.